ClearSeq Cancer HS, ILM
ClearSeq Cancer HS is a high-sensitivity cancer panel targeting COSMIC hotspots in 47 genes implicated in solid tumors and hematological cancers. This targeted cancer panel enables confident identification of somatic single nucleotide variations (SNVs) and indels from FFPE, blood and bone marrow.
The ClearSeq Cancer HS kit utilizes the HaloPlexHS technology that to generate target-enriched DNA libraries with molecular barcodes for Illumina sequencing, allowing confident detection of somatic variants of below 1% allele frequency. The kits are sufficient for either 16 reactions or 96 reactions, with automation options available.
For Research Use Only. Not for use in diagnostic procedures.